Qualitative Dynamic Contrast-Enhanced MRI Time–Intensity Curve Analysis for Differentiating Non-Progressive Treatment-Related Changes from Tumor Progression After Stereotactic Radiotherapy for Brain Metastases
Authors:
- Andrea RomanoARAndrea Romano
- Giulia MoltoniGMGiulia Moltoni
- Anna Maria AscoleseAAAnna Maria Ascolese
- Emanuela ParriEPEmanuela Parri
- Cristiana MonopoliCMCristiana Monopoli
- Paolo MatteucciPMPaolo Matteucci
- Carlo GrecoCGCarlo Greco
- Lucrezia ToppiLTLucrezia Toppi
- Sara ReinaSRSara Reina
- Sara RamellaSRSara Ramella
- Alessandro BozzaoAlessandro Bozzao
Preprint
- 5 October 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: This exploratory study assessed whether qualitative dynamic contrast-enhanced MRI (DCE-MRI) time–intensity curves (TICs) differentiate non-progressive treatment-related changes (NPTRC) from tumor recurrence after stereotactic radiotherapy for brain metastases. Methods: Thirty-two patients with 51 treated lesions underwent DCE-MRI. Five neuroradiologists inde-pendently delineated a volume of interest and classified the resulting TIC as Type A–D. Longitudinal clinical and MRI follow-up provided the reference outcome, which was recorded before the TIC framework was finalized. An A/B versus C/D grouping was evaluated as a secondary exploratory analysis. Results: Thirty-five lesions were classified as NPTRC and 16 as tumor recurrence. All 17 Type A lesions were NPTRC, and all 13 Type C/D lesions showed recurrence. Type B occurred in both groups (18 NPTRC; 3 recurrences). The A/B versus C/D grouping yielded 81.3% sensitivity and 100% specificity. The ordinal TIC analysis yielded an area under the curve of 0.952. Interobserver agree-ment was high for the four TIC categories (Fleiss’ κ = 0.889). Conclusions: Type A was associated with NPTRC, Types C/D with recurrence, and Type B represented an indeterminate pattern. These descriptive findings require independent validation before clinical use.Keywords
All Related Versions
- Version 1, 2026-10-05, Preprints
- Published version: Cancers, 18 (20), 3344.
This publication has 41 references indexed in Scilit:
- Does arterial spin labelling represent a valid alternative to other MR perfusion techniques in neuro-oncology?La radiologia medica, 2025
- DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapyJournal of Neuro-Oncology, 2019
- Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: A systematic review and meta‐analysisJournal of Magnetic Resonance Imaging, 2019
- 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Correction to: Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2La radiologia medica, 2018
- Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapyJournal of Neuro-Oncology, 2018
- Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgeryEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgeryJournal of Neuro-Oncology, 2010
- Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrenceJournal of Neurology, 2009
- MR factor analysis: Improved technology for the assessment of 2D dynamic structures of benign and malignant salivary gland tumorsJournal of Magnetic Resonance Imaging, 2008